| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.74B | 146.17B | 145.64B | 142.02B | 128.84B | 155.46B |
| Gross Profit | 23.37B | 23.60B | 25.09B | 19.00B | 19.30B | 19.37B |
| EBITDA | 196.00M | 2.20B | 14.89B | 12.67B | 16.25B | 10.11B |
| Net Income | -8.83B | -7.81B | 3.02B | 1.35B | 4.26B | 375.00M |
Balance Sheet | ||||||
| Total Assets | 111.21B | 124.63B | 140.56B | 131.80B | 137.13B | 132.89B |
| Cash, Cash Equivalents and Short-Term Investments | 15.07B | 19.97B | 19.66B | 18.25B | 18.37B | 17.95B |
| Total Debt | 19.61B | 21.02B | 24.83B | 26.57B | 26.79B | 24.28B |
| Total Liabilities | 48.62B | 59.72B | 64.13B | 61.11B | 65.05B | 62.75B |
| Stockholders Equity | 61.45B | 63.66B | 75.12B | 69.33B | 70.69B | 68.81B |
Cash Flow | ||||||
| Free Cash Flow | 1.86B | 2.68B | 8.00B | 1.32B | -3.97B | 2.23B |
| Operating Cash Flow | 6.84B | 9.35B | 14.76B | 9.49B | 3.43B | 9.69B |
| Investing Cash Flow | -2.00B | -3.75B | -6.63B | -5.31B | -1.14B | -5.26B |
| Financing Cash Flow | -4.36B | -6.41B | -7.22B | -5.31B | -2.82B | 1.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥197.65B | 15.87 | 4.41% | 3.80% | -1.50% | -32.46% | |
68 Neutral | ¥2.49T | 15.84 | 7.48% | 2.89% | 3.55% | 95.65% | |
65 Neutral | ¥95.09B | 37.30 | ― | 0.67% | 10.18% | -14.36% | |
64 Neutral | ¥28.56B | 93.87 | ― | 4.09% | 3.31% | -70.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥558.53B | 77.05 | 1.08% | 3.37% | -1.94% | -84.08% | |
51 Neutral | ¥36.65B | -5.50 | ― | 4.66% | -6.34% | -419.93% |
Moriroku Co., Ltd. has approved a syndicated loan agreement totaling 15 billion yen with a group of six financial institutions, including city, regional and trust banks, to finance the acquisition of all shares in Resonac’s Molded Components Split, Inc. The funding supports Moriroku’s previously announced plan to acquire a portion of Resonac’s mobility business, signaling a strategic push to strengthen its position in the mobility components market.
The loan, scheduled for drawdown on April 1, 2026, carries a final repayment date of March 31, 2033 and is unsecured, but it is subject to strict financial covenants on net asset levels, profitability, and leverage relative to operating cash flow. These conditions are designed to preserve Moriroku’s financial soundness as it takes on additional debt, and the company says the impact of the agreement is already reflected in its current earnings forecast, with any future revisions to be disclosed as performance evolves.
The most recent analyst rating on (JP:4249) stock is a Hold with a Yen2400.00 price target. To see the full list of analyst forecasts on Moriroku Holdings Co., Ltd. stock, see the JP:4249 Stock Forecast page.
Moriroku Company, Ltd. reported a year-on-year decline in net sales to ¥97.4 billion for the third quarter of the fiscal year ending March 2026, reflecting weaker auto parts production by major customers in China, other Asian countries and the U.S., as well as lower chemical sales. The resin-treated product business was hit particularly hard, while the chemicals segment also contracted but to a lesser extent.
Despite lower sales and higher procurement costs due to inflation, operating profit edged up to ¥2.0 billion, helped by price optimization, cost reductions, the deconsolidation of a Mexican subsidiary and lower depreciation in China after prior impairment losses. Ordinary profit rose sharply to ¥1.8 billion on reduced foreign exchange losses, and net profit climbed to ¥0.8 billion even after the absence of a prior-year gain on asset sales, indicating improved earnings quality and some resilience in profitability amid a weak demand environment.
The most recent analyst rating on (JP:4249) stock is a Hold with a Yen2400.00 price target. To see the full list of analyst forecasts on Moriroku Holdings Co., Ltd. stock, see the JP:4249 Stock Forecast page.
Moriroku Company, Ltd. reported consolidated net sales of ¥97.48 billion for the nine months ended December 31, 2025, down 9.7% year on year, but operating profit rose 8.5% to ¥2.06 billion and ordinary profit more than doubled, driving profit attributable to owners of parent to ¥896 million. The equity ratio improved to 53.2% as total assets edged down, while the company maintained its full-year forecast calling for lower sales but higher ordinary profit and plans to lift the annual dividend to ¥115 per share, signaling confidence in earnings resilience amid portfolio adjustments including changes in its consolidated subsidiaries.
For the full year to March 31, 2026, Moriroku projects net sales of ¥131.2 billion, a 10.2% decline, but expects ordinary profit to climb 27% to ¥2.8 billion and profit attributable to owners of parent to reach ¥1.8 billion, translating into basic earnings per share of ¥125.73. The unchanged earnings guidance and higher interim and projected year-end dividends underscore management’s commitment to shareholder returns, even as the group reshapes its global footprint by adding Moriroku Chemicals India Private Limited and excluding Moriroku Technology De Mexico S.A. de C.V. from the scope of consolidation.
The most recent analyst rating on (JP:4249) stock is a Hold with a Yen2400.00 price target. To see the full list of analyst forecasts on Moriroku Holdings Co., Ltd. stock, see the JP:4249 Stock Forecast page.